Repositioning of bromocriptine for treatment of acute myeloid leukemia

BACKGROUND: Treatment for acute myeloid leukemia (AML) has not significantly changed in the last decades and new therapeutic approaches are needed to achieve prolonged survival rates. Leukemia stem cells (LSC) are responsible for the initiation and maintenance of AML due to their stem-cell propertie...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Transl Med
Egile Nagusiak: Lara-Castillo, María Carmen, Cornet-Masana, Josep Maria, Etxabe, Amaia, Banús-Mulet, Antònia, Torrente, Miguel Ángel, Nomdedeu, Meritxell, Díaz-Beyá, Marina, Esteve, Jordi, Risueño, Ruth M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2016
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5015257/
https://ncbi.nlm.nih.gov/pubmed/27604463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-1007-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak